Each person ’sEach person concept the Obama administration   but there ’s been a lot of skepticism from the medical community about . "" Even so , people in the industry are optimistic about where the area ’s going ." ’"We’’re starting to really come to appreciate that not every patient is going to benefit from every drug , " Tom Zioncheck , senior director in business development at Genentech , said.